TW201612316A - Porcine pseudorabies virus gene deletion strain, vaccine composition, and preparation method and application of vaccine composition - Google Patents
Porcine pseudorabies virus gene deletion strain, vaccine composition, and preparation method and application of vaccine compositionInfo
- Publication number
- TW201612316A TW201612316A TW104127275A TW104127275A TW201612316A TW 201612316 A TW201612316 A TW 201612316A TW 104127275 A TW104127275 A TW 104127275A TW 104127275 A TW104127275 A TW 104127275A TW 201612316 A TW201612316 A TW 201612316A
- Authority
- TW
- Taiwan
- Prior art keywords
- vaccine composition
- porcine pseudorabies
- pseudorabies virus
- preparation
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16762—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16771—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20071—Demonstrated in vivo effect
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410418379.8A CN104250640A (zh) | 2014-08-22 | 2014-08-22 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201612316A true TW201612316A (en) | 2016-04-01 |
Family
ID=52185894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW104127275A TW201612316A (en) | 2014-08-22 | 2015-08-21 | Porcine pseudorabies virus gene deletion strain, vaccine composition, and preparation method and application of vaccine composition |
Country Status (7)
Country | Link |
---|---|
US (3) | US10548972B2 (zh) |
EP (1) | EP3012322B1 (zh) |
JP (1) | JP6368725B2 (zh) |
CN (2) | CN104250640A (zh) |
DK (1) | DK3012322T3 (zh) |
TW (1) | TW201612316A (zh) |
WO (1) | WO2016026264A1 (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104250640A (zh) * | 2014-08-22 | 2014-12-31 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CN111560355A (zh) * | 2015-03-20 | 2020-08-21 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用 |
CN106282132A (zh) * | 2015-05-11 | 2017-01-04 | 中国农业科学院上海兽医研究所 | 伪狂犬病毒变异株的弱毒株及其应用 |
CN106310248B (zh) * | 2015-06-18 | 2019-12-20 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒活疫苗组合物用于治疗猪伪狂犬病的用途 |
CN108251382B (zh) * | 2016-12-29 | 2021-08-20 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用 |
CN107828741B (zh) * | 2017-11-07 | 2021-01-12 | 江苏省农业科学院 | 伪狂犬病病毒双基因缺失弱毒株及其应用 |
CN108553641A (zh) * | 2018-05-15 | 2018-09-21 | 贵州都匀市黔昌畜牧发展有限责任公司 | 一种伪狂犬病免疫方法 |
CN109609468B (zh) * | 2018-12-10 | 2020-06-30 | 畜科生物工程有限公司 | 一种六基因缺失的猪伪狂犬病毒、猪伪狂犬病疫苗以及制备方法 |
CN109337874B (zh) * | 2018-12-10 | 2020-05-12 | 畜科生物工程有限公司 | 一种重组猪伪狂犬病毒及其应用和重组猪伪狂犬病活疫苗 |
CN109750005A (zh) * | 2018-12-26 | 2019-05-14 | 河南农业大学 | 一种猪伪狂犬病重组病毒株及其构建方法 |
CN109750007A (zh) * | 2019-02-01 | 2019-05-14 | 华南农业大学 | 双表达gC基因的伪狂犬病毒gE/gI缺失突变株及其构建和应用 |
CN110241090B (zh) * | 2019-05-07 | 2023-10-13 | 江苏南农高科技股份有限公司 | 一种全悬浮细胞培养生产猪伪狂犬病毒抗原的方法 |
CN110257345B (zh) * | 2019-07-18 | 2021-07-16 | 河南农业大学 | 一种猪伪狂犬病双基因缺失变异突变病毒毒株及其构建方法 |
CN110527669B (zh) * | 2019-09-06 | 2021-07-06 | 中牧实业股份有限公司 | 一种猪伪狂犬病病毒基因缺失毒株及其构建方法和应用 |
CN112831477A (zh) * | 2019-11-25 | 2021-05-25 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 表达猪瘟病毒E2蛋白和猪圆环病毒Cap蛋白的重组伪狂犬病病毒株及其构建方法和用途 |
CN111154733A (zh) * | 2020-01-09 | 2020-05-15 | 天津瑞普生物技术股份有限公司 | 一种伪狂犬病毒弱毒株及应用 |
CN111748529B (zh) * | 2020-06-19 | 2022-01-11 | 国药集团动物保健股份有限公司 | 猪伪狂犬病病毒毒株及其应用 |
CN112342201B (zh) * | 2020-11-04 | 2023-01-03 | 武汉科前生物股份有限公司 | 一种通过CRISPR/Cas9制备的猪伪狂犬病弱毒株及其应用 |
CN112501133B (zh) * | 2020-12-01 | 2022-05-24 | 山东信得科技股份有限公司 | 一种伪狂犬病毒qd株三基因缺失致弱株 |
CN115216451A (zh) * | 2021-04-16 | 2022-10-21 | 硕腾服务有限责任公司 | 伪狂犬病病毒疫苗 |
CN113444697A (zh) * | 2021-04-19 | 2021-09-28 | 温氏食品集团股份有限公司 | 重组猪伪狂犬病毒及其制备方法和应用 |
CN113957171A (zh) * | 2021-10-26 | 2022-01-21 | 苏州药明检测检验有限责任公司 | 一种组织半数感染法染色测定伪狂犬病毒滴度的方法 |
CN116064557A (zh) * | 2022-09-15 | 2023-05-05 | 华中农业大学 | 激活猪的ogfod2基因表达的制剂在制备猪抗伪狂犬病毒感染药物中的应用 |
CN116790509B (zh) * | 2023-06-28 | 2024-02-02 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 一种分泌抗猪伪狂犬病病毒gB蛋白抗体的单克隆杂交瘤细胞株及其应用 |
CN117384863B (zh) * | 2023-10-18 | 2024-04-05 | 武汉科前生物股份有限公司 | 猪伪狂犬病病毒自然传代弱毒变异株js18-150及其应用 |
CN117106736B (zh) * | 2023-10-25 | 2024-02-20 | 江西农业大学 | 利用cbe构建三基因缺失prv毒株的方法和应用 |
CN117126818B (zh) * | 2023-10-25 | 2024-02-02 | 江西农业大学 | 利用ABE构建gE基因缺失PRV毒株的方法和应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
US4514497B1 (en) * | 1983-12-30 | 1998-02-24 | Novagene Inc | Modified live pseudorabies viruses |
TW289731B (zh) * | 1992-07-09 | 1996-11-01 | Akzo Nv | |
FR2781159B1 (fr) | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
CN100354414C (zh) * | 2005-09-29 | 2007-12-12 | 华中农业大学 | 一种伪狂犬病gEˉ/gIˉ基因缺失毒株、含有该毒株的灭活疫苗及应用 |
NZ572808A (en) | 2006-05-19 | 2011-11-25 | Water And Eliza Hall Inst Of Medical Res | Compositions for raising an immune response comprising an antigen and a targeting moiety for lymph-resident dendritic cells |
CN101186902B (zh) * | 2006-07-04 | 2010-11-10 | 四川农业大学 | 伪狂犬病病毒sa215和伪狂犬病毒多基因缺失疫苗及其制备方法 |
JP2011507522A (ja) | 2007-12-21 | 2011-03-10 | ワイス・エルエルシー | 豚サーコウイルスに対してブタを免疫化するための方法および組成物 |
WO2009143865A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
BR112013030321A2 (pt) * | 2011-05-27 | 2017-07-11 | Sinovet Beijing Biotechnology Co Ltd | composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv. |
CN102994458B (zh) | 2012-11-26 | 2014-04-02 | 中国农业科学院哈尔滨兽医研究所 | 猪伪狂犬病病毒强毒株、其基因缺失疫苗株及其应用 |
CN103756977B (zh) | 2013-12-11 | 2016-01-06 | 姜平 | 猪伪狂犬病变异株gE和gI基因缺失病毒株及其应用 |
CN103627678B (zh) | 2013-12-19 | 2016-03-02 | 姜平 | 一种猪伪狂犬病病毒变异株prv-zj01及应用 |
CN103923884B (zh) | 2014-02-21 | 2017-03-29 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CN103981153B (zh) | 2014-05-29 | 2017-07-07 | 中国兽医药品监察所 | 伪狂犬病病毒双荧光标记缺失病毒的构建 |
CN104250640A (zh) | 2014-08-22 | 2014-12-31 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
-
2014
- 2014-08-22 CN CN201410418379.8A patent/CN104250640A/zh active Pending
-
2015
- 2015-01-06 CN CN201510004421.6A patent/CN104862286B/zh active Active
- 2015-01-06 DK DK15808317.0T patent/DK3012322T3/da active
- 2015-01-06 EP EP15808317.0A patent/EP3012322B1/en active Active
- 2015-01-06 US US14/901,981 patent/US10548972B2/en active Active
- 2015-01-06 JP JP2015563126A patent/JP6368725B2/ja active Active
- 2015-01-06 WO PCT/CN2015/070221 patent/WO2016026264A1/zh active Application Filing
- 2015-08-21 TW TW104127275A patent/TW201612316A/zh unknown
-
2016
- 2016-02-26 US US15/054,404 patent/US20160279232A1/en not_active Abandoned
- 2016-07-19 US US15/213,662 patent/US10201605B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10201605B2 (en) | 2019-02-12 |
US20160317650A1 (en) | 2016-11-03 |
CN104250640A (zh) | 2014-12-31 |
US10548972B2 (en) | 2020-02-04 |
US20160279232A1 (en) | 2016-09-29 |
US20160281065A1 (en) | 2016-09-29 |
WO2016026264A1 (zh) | 2016-02-25 |
DK3012322T3 (da) | 2019-10-07 |
EP3012322A1 (en) | 2016-04-27 |
CN104862286A (zh) | 2015-08-26 |
CN104862286B (zh) | 2018-09-11 |
EP3012322B1 (en) | 2019-08-28 |
JP6368725B2 (ja) | 2018-08-01 |
EP3012322A4 (en) | 2016-07-20 |
JP2016531545A (ja) | 2016-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201612316A (en) | Porcine pseudorabies virus gene deletion strain, vaccine composition, and preparation method and application of vaccine composition | |
MX2016012845A (es) | Vacuna contra el virus de la diarrea epidemica porcina. | |
PH12017500727A1 (en) | Modified virus-like particles of cmv | |
MX2022002106A (es) | Formulaciones de vacuna de vial unico. | |
BR112017008165A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
MX2015008847A (es) | Composiciones inmunogenicas de virus de influenza y usos de las mismas. | |
AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
TW201613558A (en) | Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus | |
PH12014501174A1 (en) | Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof | |
PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
MX2017004897A (es) | Cepas vacunales recombinantes de listeria y metodos para usar las mismas en la inmunoterapia contra el cancer. | |
MX2016016746A (es) | Composiciones de vacuna con adyuvante dual, preparacion y usos. | |
MX2018004598A (es) | Cepas vacunales recombinantes de listeria y métodos para usar las mismas en la inmunoterapia contra el cáncer. | |
NZ729519A (en) | Methods and compositions for intra-nasal immunization with recombinant mva encoding flagellin | |
MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
BR112017002440A2 (pt) | vírus da diarreia epizoótica porcina mutante para utilização em uma vacina | |
MX2021000951A (es) | Composición que contiene vacuna contra la influenza. | |
BR112018010679A2 (pt) | métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina | |
PH12018502436A1 (en) | Multivalent vaccines major swine viral diseases | |
MX2015013304A (es) | Vacunas de nucleoproteina de la influenza. | |
BR112014020025A8 (pt) | Vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas | |
WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
PH12017501100B1 (en) | Recombinant swinepox virus and vaccines | |
PH12018502576A1 (en) | Multivalent recombinant spv | |
MX2017006744A (es) | Composiciones adyuvantes y metodos relacionados. |